Recruiting
A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.
About this study
The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.
- Condition
- PTCL
- Tested
- chidamide
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 3
- Minimum age: 18 years
- Study condition: PTCL
- (1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.
Exclusion 1
- (1) Patients with other types of lymphomas; (2) Pregnant women.
Where
1 site, 1 recruiting
Hematological Department, People's Hospital of Jiangsu Province
Nanjing, Jiangsu, China
Contact
-
wei xu
+862568302182 xuwei10000@hotmail.com
Potential match only. Final eligibility is determined by the study team.